Finance

Beta
Lists
054670:KOSDAQ
Daehan Nupharm Co Ltd
₩5,680.00
+0.35%
(+20.00) 1D
Jun 12, 3:30:21 PM GMT+9  ·   KRW
All symbols
SymbolPriceChange% Change
Generating top insights for 054670...
Open
₩5,700
High
₩5,840
Low
₩5,660
Mkt. cap
81.54B
Avg. vol.
65.34K
Volume
0.00
Dividend
1.76%
Quarterly dividend
₩25
Ex-dividend date
Dec 27, 2023
P/E ratio
5.09
52-wk high
₩8,810
52-wk low
₩5,360
EPS
₩1,117
Shares outstanding
14.35M
No. of employees
378
Open
₩5,700
High
₩5,840
Low
₩5,660
Mkt. cap
81.54B
Avg. vol.
65.34K
Volume
0.00
Dividend
1.76%
Quarterly dividend
₩25
Ex-dividend date
Dec 27, 2023
P/E ratio
5.09
52-wk high
₩8,810
52-wk low
₩5,360
EPS
₩1,117
Shares outstanding
14.35M
No. of employees
378
News stories
From sources across the web
About Daehan Nupharm Co Ltd
CEO-
Employees378
Founded1984
Headquarters-
SectorPharmaceutical industry
Websitedhnp.co.kr
Previous reportsAll values in KRW
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in KRW
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
49.87B
48.88B
51.79B
54.84B
Cost of goods sold
26.41B
26.80B
30.63B
31.79B
Cost of revenue
26.41B
26.80B
30.63B
31.79B
Research and development expenses
2.13B
2.27B
1.11B
2.35B
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
17.70B
17.06B
17.94B
17.15B
Operating expense
20.40B
20.00B
18.82B
19.92B
Total operating expenses
46.81B
46.80B
49.45B
51.71B
Operating income
3.06B
2.08B
2.34B
3.14B
Other non operating income
-20.52M
66.14M
662.78M
-67.89M
EBT including unusual items
3.86B
3.36B
4.42B
3.53B
EBT excluding unusual items
2.91B
1.72B
2.41B
2.42B
Income tax expense
851.54M
750.00M
-2.65B
531.04M
Effective tax rate
22.07%
22.33%
-59.91%
15.05%
Other operating expenses
132.51M
219.42M
174.10M
331.19M
Net income
3.01B
2.61B
7.06B
3.00B
Net profit margin
6.03%
5.34%
13.64%
5.47%
Earnings per share
-
-
-
-
Interest and investment income
83.91M
56.87M
63.85M
48.89M
Interest expense
-383.64M
-338.10M
-509.73M
-487.74M
Net interest expenses
-299.73M
-281.24M
-445.88M
-438.86M
Depreciation and amortization charges
478.62M
472.58M
-113.13M
303.00M
EBITDA
4.14B
3.16B
3.44B
4.25B
Gain or loss from assets sale
2.00K
3.00K
289.84M
372.00K
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer